$TG

Gottwald James T. sold $6K of TG (indirect holdings)

Gottwald James T. sold 780 indirectly-held shares of TREDEGAR CORP (TG) at $8.00 on 2026-08-21.

Original reporting
SEC EDGAR · Gottwald James T.
Published Aug 25, 2026, 7:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 7:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TG
Neutral
high confidence
Mentioned
$TG
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TGNeutralLow
01

Why it matters

The disclosed sale is routine and unlikely to move the stock.

02

Market read

Low relevance; the filing provides a factual update on insider holdings with minimal trading implication.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 3/10Novelty 4/10Timing: filed today

Background

TREDEGAR Corp (TG) is a medical device company listed on NYSE. Insider transactions are regularly disclosed via Form 4.

Company-level read

Ticker impact

$TGNeutralHigh confidence
Context

Form 4 shows insider James T. Gottwald sold 780 shares for $6,242, reducing his holdings to 361,140 shares.

Expected impact

Likely negligible price movement.

Evidence & confidence

The transaction size is small relative to float and total holdings; no pre‑arranged plan and no material change in ownership.

Market effects

None; the sale does not affect the broader healthcare equipment sector.

No regional effect.

Not globally relevant.

Counterpoint

Even small insider sales can signal confidence issues; monitor for further disposals.

Key entities

  • James T. Gottwald

    10% owner of TREDEGAR Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TGMed

Tredegar Soars on Q2 Financials

Tredegar Corp (NYSE:TG) reported Q2 2026 results for the period ended June 30, 2026. Net income from continuing operations rose to $6.0 million, or $0.17 per diluted share, from $1.8 million, or $0.05 per share, in Q2 2025. Excluding special items, net income was $6.4 million, or $0.18 per share. Aluminum Extrusions EBITDA was $14.5 million versus $9.3 million in Q2 2025.

$TGMed

TREDEGAR CORP (TG): Results of Operations and Financial Condition

TREDEGAR CORP (TG) filed an SEC Form 8-K — Results of Operations and Financial Condition. TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS • Increased second quarter 2026 results, with net income from continuing operations of $6.0 million, or $0.17 per diluted share, for the second quarter of 2026 compared to $1.8 million, or $0.05 per diluted share, for the second quarte

$DELLLow

Silver Lake Partners V DE (AIV), L.P. (Durban Egon) sold $14.9M of DELL (indirect holdings)

Silver Lake Partners V DE (AIV), L.P. sold 26,990 indirectly-held shares of Dell Technologies Inc. (DELL) at an average of $552.79 ($542.78–$564.46, $14.92M total) across 22 trades on 2026-09-15. Filed jointly with Silver Lake Technology Associates V, L.P. (Director), SLTA V (GP), L.L.C. (Director), Silver Lake Group, L.L.C. (Director) and Durban Egon (Director).